- Country: Panama
- Summary: Supply, Storage, Transport and Partial Delivery According to the Need for 222 Roads of the Atezolizumab 1200 Mg Drug, Concentrated for Solution for Intravenous Road Infusion, I.v. Fta: 106838
- PAT Ref No: 83698880
- Deadline: 17 Jul 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PAB 954600.00
- Notice Type: Tender
- Document Ref. No.: 2023-0-12-11-08-LV-022219
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply, storage, transport and partial delivery according to the need for 222 roads of the Atezolizumab 1200 mg drug, concentrated for solution for intravenous road infusion, I.V. FTA: 106838
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply, Storage, Transport and Partial Delivery According to the Need for 222 Roads of the Atezolizumab 1200 Mg Drug, Concentrated for Solution for Intravenous Road Infusion, I.v. Fta: 106838 - Panama Tender
The MINISTRY OF HEALTH, a Government sector organization in Panama, has announced a new tender for Supply, Storage, Transport and Partial Delivery According to the Need for 222 Roads of the Atezolizumab 1200 Mg Drug, Concentrated for Solution for Intravenous Road Infusion, I.v. Fta: 106838. This tender is published on PanamaTenders under PAT Ref No: 83698880 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-07-17.
The estimated tender value is PAB 954600.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
